undamentalytics Newsletter

Broadrick Dale: insider trades

10% owner at Biorestorative Therapies, Inc. 20 open-market purchases and no sales not made under a pre-set plan, reported from May 9, 2019 to February 12, 2024.

Would copying Broadrick Dale’s purchases have beaten the S&P 500?

Too few purchases to judge. None of their purchases has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. None of their purchases could be priced, so there is no copy portfolio. None of these trades can be measured yet: either the window after the report has not finished or the share price was under $5 when it was reported.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Broadrick Dale: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Biorestorative Therapies, Inc. BRTX —200May 9, 2019February 12, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
February 12, 2024February 8, 2024 BRTX Purchase $206,023 not yetnot yetnot yet
February 9, 2024February 7, 2024 BRTX Purchase $162,255 not yetnot yetnot yet
September 18, 2023September 14, 2023 BRTX Purchase $32,000 not yetnot yetnot yet
March 3, 2023November 30, 2022 BRTX Purchase $17,705 not yetnot yetnot yet
June 17, 2022June 15, 2022 BRTX Purchase $12,084 not yetnot yetnot yet
June 9, 2022June 7, 2022 BRTX Purchase $27,384 not yetnot yetnot yet
June 7, 2022June 3, 2022 BRTX Purchase $20,670 not yetnot yetnot yet
June 3, 2022June 1, 2022 BRTX Purchase $41,090 not yetnot yetnot yet
June 1, 2022May 27, 2022 BRTX Purchase $39,555 not yetnot yetnot yet
May 31, 2022May 26, 2022 BRTX Purchase $17,374 not yetnot yetnot yet
April 8, 2022April 6, 2022 BRTX Purchase $14,150 not yetnot yetnot yet
April 7, 2022April 5, 2022 BRTX Purchase $262,640 not yetnot yetnot yet
April 1, 2022March 29, 2022 BRTX Purchase $76,088 not yetnot yetnot yet
March 29, 2022March 1, 2022 BRTX Purchase $794,110 not yetnot yetnot yet
January 8, 2020January 6, 2020 BRTX Purchase $84,602 not yetnot yetnot yet
December 10, 2019April 4, 2019 BRTX Purchase $68,561 not yetnot yetnot yet
November 1, 2019October 21, 2019 BRTX Purchase $50,940 not yetnot yetnot yet
October 18, 2019May 9, 2019 BRTX Purchase $642,411 not yetnot yetnot yet
August 23, 2019August 21, 2019 BRTX Purchase $49,954 not yetnot yetnot yet
May 9, 2019February 26, 2019 BRTX Purchase $606,657 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Broadrick Dale traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.